Global /India /Healthcare /Drug Manufacturers - General /SUPRIYA
chevron_leftBack
Supriya Lifescience Ltd. logo

Supriya Lifescience Ltd.

SUPRIYA
NSE: SUPRIYA Delayed
694.90INR -0.5%
7.29 USD
As of 6 June 2026, Supriya Lifescience Ltd. has a market cap of $586.91M USD, ranking #14092 globally and #755 in India. It ranks #1255 in the Healthcare sector, and #466 in the Drug Manufacturers - General industry.
Global Rank
14092
Country Rank
755
Sector Rank
1255
Industry Rank
466
Key Stats
Market Cap
$586.91MUSD
56.2B INR
Enterprise Value
$578.9MUSD
55.22B INR
Revenue (TTM)
$76.81MUSD
7.35B INR
EBITDA (TTM)
$27.39MUSD
2.61B INR
Net Income (TTM)
$19.35MUSD
1.85B INR
EBITDA Margin
36%
Profit Margin
25%
PE Ratio
30.3
Forward PE
23.8
PS Ratio
7.6
PB Ratio
5.2
EV/EBITDA
21.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
515
Founded
1987
Website
supriyalifescience.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.5% 4.1% 17% 2.4% -7.7% 2.8%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
SUPRIYA
Supriya Lifescience Ltd
ISIN: INE07RO01027
Shares Out.:
80.483M1 Shares Float: 23.469M2
TV:
SA:
YF:
GF:
BA:
MS:
694.90 INR
Bombay Stock Exchange
MIC: XBOM
543434 (SUPRIYA)
Supriya Lifescience Ltd
ISIN: INE07RO01027
TV:
SA:
YF:
GF:
BA:
MS:
699.55 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Supriya Lifescience Ltd.

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.57B
4.27T INR
7K%
39.1
DIVISLAB
$18.12B
1.73T INR
3K%
70.0
$14.95B
1.43T INR
2K%
63.0
$11.57B
1.11T INR
2K%
19.6
MANKIND
$9.73B
931.67B INR
2K%
52.2
ZYDUSLIFE
$9.57B
916.53B INR
2K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
130K%
38.1
JNJ
$547.28B
93K%
26.4
ABBV
$360.63B
61K%
97.4
$324.68B
256.25B CHF
55K%
19.9
AZN
$289.43B
215.59B GBP
49K%
27.6
NOVN
$277.35B
218.9B CHF
47K%
20.5
chevron_leftBack